MedPath

贵州汉方药业有限公司

Ownership
-
Established
1996-03-19
Employees
-
Market Cap
-
Website
http://117.187.198.75:80

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

80

NMPA:80

Drug Approvals

Compound Calcium Carbonate Effervescent Tablets

Product Name
复方碳酸钙泡腾片
Approval Number
国药准字H52020513
Approval Date
Apr 3, 2025
NMPA

感冒灵颗粒

Approval Number
国药准字Z52020165
Approval Date
Jul 11, 2024
NMPA

罗汉果止咳胶囊

Approval Number
国药准字Z20090385
Approval Date
Nov 6, 2023
NMPA

杜仲补天素胶囊

Approval Number
国药准字Z20123111
Approval Date
Jun 26, 2022
NMPA

半夏止咳糖浆

Approval Number
国药准字Z52020418
Approval Date
Apr 2, 2021
NMPA

肥儿糖浆

Approval Number
国药准字Z52020421
Approval Date
Apr 2, 2021
NMPA

疣迪搽剂

Approval Number
国药准字Z20053056
Approval Date
Feb 28, 2020
NMPA

复方丹参片

Approval Number
国药准字Z20093705
Approval Date
Jan 16, 2020
NMPA

复方川贝精片

Approval Number
国药准字Z52020164
Approval Date
Dec 23, 2019
NMPA

乳泉颗粒

Approval Number
国药准字Z19993255
Approval Date
Dec 23, 2019
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.